Literature DB >> 18372283

Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.

H-M Baek, J-H Chen, O Nalcioglu, M-Y Su.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18372283      PMCID： PMC2613189          DOI： 10.1093/annonc/mdn121

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  7 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.

Authors:  Hyun-Man Baik; Min-Ying Su; Hon Yu; Rita Mehta; Orhan Nalcioglu
Journal:  MAGMA       Date:  2006-05-09       Impact factor: 2.310

3.  Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Authors:  K A Kvistad; I J Bakken; I S Gribbestad; B Ehrnholm; S Lundgren; H E Fjøsne; O Haraldseth
Journal:  J Magn Reson Imaging       Date:  1999-08       Impact factor: 4.813

4.  [Imaging methods for evaluating the response of breast carcinoma to preoperative chemotherapy].

Authors:  H Junkermann; D von Fournier
Journal:  Radiologe       Date:  1997-09       Impact factor: 0.635

5.  Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy.

Authors:  A Rieber; H-J Brambs; A Gabelmann; V Heilmann; R Kreienberg; T Kühn
Journal:  Eur Radiol       Date:  2002-02-14       Impact factor: 5.315

6.  Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.

Authors:  J Herrada; R B Iyer; E N Atkinson; N Sneige; A U Buzdar; G N Hortobagyi
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

7.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  N R Jagannathan; M Kumar; V Seenu; O Coshic; S N Dwivedi; P K Julka; A Srivastava; G K Rath
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640
  7 in total
  19 in total

1.  The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging.

Authors:  M D Dorrius; R M Pijnappel; M C van der Weide Jansen; L Jansen; P Kappert; M Oudkerk; P E Sijens
Journal:  Eur Radiol       Date:  2011-11-11       Impact factor: 5.315

2.  Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.

Authors:  Maria D Cao; Mailin Döpkens; Balaji Krishnamachary; Farhad Vesuna; Mayur M Gadiya; Per E Lønning; Zaver M Bhujwalla; Ingrid S Gribbestad; Kristine Glunde
Journal:  NMR Biomed       Date:  2012-01-26       Impact factor: 4.044

3.  Targeting choline phospholipid metabolism: GDPD5 and GDPD6 silencing decrease breast cancer cell proliferation, migration, and invasion.

Authors:  Maria Dung Cao; Menglin Cheng; Asif Rizwan; Lu Jiang; Balaji Krishnamachary; Zaver M Bhujwalla; Tone F Bathen; Kristine Glunde
Journal:  NMR Biomed       Date:  2016-06-30       Impact factor: 4.044

4.  MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Authors:  Patrick J Bolan; Eunhee Kim; Benjamin A Herman; Gillian M Newstead; Mark A Rosen; Mitchell D Schnall; Etta D Pisano; Paul T Weatherall; Elizabeth A Morris; Constance D Lehman; Michael Garwood; Michael T Nelson; Douglas Yee; Sandra M Polin; Laura J Esserman; Constantine A Gatsonis; Gregory J Metzger; David C Newitt; Savannah C Partridge; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2016-12-16       Impact factor: 4.813

Review 5.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

6.  A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T.

Authors:  Jiani Hu; Wenzheng Feng; Jia Hua; Quan Jiang; Yang Xuan; Tao Li; E Mark Haacke
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

Review 7.  In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients.

Authors:  Uma Sharma; Hyeon Man Baek; Min Ying Su; Naranamangalam R Jagannathan
Journal:  NMR Biomed       Date:  2011-01-28       Impact factor: 4.044

Review 8.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

9.  Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy.

Authors:  Hyeon-Man Baek; Jeon-Hor Chen; Ke Nie; Hon J Yu; Shadfar Bahri; Rita S Mehta; Orhan Nalcioglu; Min-Ying Su
Journal:  Radiology       Date:  2009-03-10       Impact factor: 11.105

10.  Dixon imaging-based partial volume correction improves quantification of choline detected by breast 3D-MRSI.

Authors:  Lenka Minarikova; Stephan Gruber; Wolfgang Bogner; Katja Pinker-Domenig; Pascal A T Baltzer; Thomas H Helbich; Siegfried Trattnig; Marek Chmelik
Journal:  Eur Radiol       Date:  2014-09-14       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.